Haleon · 4 months ago
2026 Intern: Product Design and AD(12 weeks, June 2026 start)
Richmond Sherwood
Internship
Onsite
Intern
$24.50/hr - $24.50/hr
Start in 2026 SummerHaleon is a purpose-driven, world-class consumer healthcare company focused on delivering better everyday health with humanity. They are seeking a Development Intern to assist in innovative product development, working with the Innovation & Technology and Analytical teams to evaluate new technologies for application in the VMS space.
ConsumerHealth CareMedical
No H1B
Responsibilities
Design, plan, and conduct product development activities, including pre-formulation and formulation
Perform analytical testing of active ingredients and define dissolution profiles of new products
Analyze data and present results
Implement written procedures & departmental quality documentation (including SOP’s, batch documentation, validation protocols & reports) and ensures work is conducted accordingly
Deliver all EHS standards and expectations on site and within the laboratories
Ensures work is always conducted following good scientific practice, Good Laboratory Practices, Good Manufacturing Practices (where required) and maintains accurate experimental records
Qualification
Required
Graduating with a Bachelor's degree program with a background in Chemistry, Pharmacy, Engineering, Food Science, or related sciences
Ability to work on site in Richmond, VA. (Relocation not included)
Candidate must be available to work full-time through the 12-week internship (approximately 40 hours/week, Monday – Friday)
Must be eligible to work in the US at the time of, and for the duration of employment. Employees will be required to furnish evidence of US work authorization. Applicant must not require future sponsorship for an employment visa status
Preferred
A cumulative GPA of 3.0 is preferred
Company
Haleon
Haleon is to deliver better everyday health with humanity.
Founded in 2022
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$3.06B2025-01-16Post Ipo Secondary· $3.06B
2022-07-18IPO
Leadership Team
Brian McNamara
Chief Executive Officer
Carl Haney
Chief R&D Officer
Recent News
2026-01-11
2026-01-11
Company data provided by crunchbase